mRNA vaccines: A novel weapon to control infectious diseases

мРНК-вакцины: новое оружие для контроля инфекционных заболеваний
Yuying Tian, Zhuoya Deng, Penghui Yang
2022-10-04

SARS-CoV-2infectious diseasesinnate immune responsemRNA vaccinesvaccine delivery systems
Infectious diseases have always threatened human life, but with the development of vaccines, effective strategies for preventing and controlling these diseases have become available. The global outbreak of COVID-19 ushered in the advent of mRNA vaccine technologies, which quickly led to the introduction of mRNA vaccines effective against SARS-CoV-2. The success of this approach has stimulated research into the use of mRNA vaccines in the fight against other emerging as well as remerging infectious diseases. This review examines the constructive strategies and delivery systems used in mRNA vaccines and provides an overview of current clinical trials of those vaccines in the prevention of infectious diseases. The underlying mechanisms of mRNA vaccines are also discussed, including the double-edged sword of the innate immune response. Finally, the challenges but also the potential of mRNA vaccines are considered.
1
COVID-19 demonstrated that mRNA vaccine technology can rapidly produce effective vaccines against SARS-CoV-2.
2
Effective mRNA vaccine design depends on constructive strategies and delivery systems that enable therapeutic messenger RNA use.
3
Innate immune activation has a double-edged role in mRNA vaccination, while delivery, safety, and other challenges constrain broader application.
4
The review summarizes current clinical trials evaluating mRNA vaccines for infectious-disease prevention.
5
The success of SARS-CoV-2 mRNA vaccines has accelerated development for emerging and re-emerging infectious diseases.
6
mRNA vaccines show substantial potential as a versatile strategy for controlling infectious diseases.

mRNA vaccines for preventing and controlling infectious diseases

vaccine design and delivery strategies, clinical development, mechanisms of action, innate immune responses, challenges, and potential

Publication Details
Publication Date
2022-10-04
Journal
Publisher
ISSN
Cited by
28
Access Type
Author Information
Authors
Yuying Tian
Zhuoya Deng
Penghui Yang
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%